News

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...
Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...
MONDAY, July 7, 2025 (HealthDay News) — Adults as young as 50 may now qualify for an RSV vaccine if they have certain health ...
Indian pediatric experts report that Respiratory Syncytial Virus (RSV) causes a significant number of infant respiratory ...
At 21 months old, Olivia is bright, bubbly, and full of joy. But instead of running around like other toddlers, she’s spent ...
With the 2025 influenza season starting earlier than usual, the NICD urges South Africans to stay vigilant against seasonal ...
Citing Indian Council for Medical Research (ICMR) and published studies, Dr Bhavesh Kotak, Head of Medical Affairs at Dr ...
RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...
The RSV vaccination eligibility age has been lowered from 60 years to 50 years according to an update on the CDC website.
Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.
The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...